News

This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Christina Flores, LVN, who works in vaccine and infectious disease clinical trials. What is your background? I grew up in Highland Park, California, and began my ...

This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Sarah Ruiz, BSN, RN, PHN, who works in bone marrow transplant and pediatric clinical trials. What is your background? I grew up in Texas, primarily the ...

Restaurants in the United States are known for generous portions, often serving far more food than most adults need in a single meal. Those oversized portions have long been linked to overeating and, over time, to higher rates of obesity and chronic disease. A new study conducted in real restaurants suggests there may be a ...

While the typical assumption would be that it takes a major academic campus to foster medical innovation, Kaiser Permanente is proving that wrong. The Kaiser Permanente Riverside Medical Center has become a hub for clinical trial innovation under the direction of Vivienne Hau, MD, PhD, a medical and surgical vitreoretinal specialist who has built a retinal ...

A new Kaiser Permanente study suggests that managing high blood pressure may help women with advanced breast cancer live longer. The study found that women who took more than one type of blood pressure drug were much less likely to die than those taking just one type.

Hui Zhou PhD, MS, is the biostatistician lead in the Division of Epidemiologic Research for the Department of Research & Evaluation. There she collaborates with epidemiologists and clinical investigators on research studies ranging from conditions like hypertension, diabetes, chronic kidney disease, cardiovascular disease, and bone fractures. Dr. Zhou has extensive research experience in prediction model ...

A Kaiser Permanente study found that the PREVENT cardiovascular risk equation had strong overall ability to predict 10-year cardiovascular disease risk in Asian, Native Hawaiian, and Other Pacific Islander adults. However, its accuracy differed across specific Asian ethnic subgroups and showed consistent patterns of over- and under-estimating when grouping by race and ethnicity. The study went ...

For years, people living with relapsing forms of multiple sclerosis (MS) have depended on powerful medications to keep their disease under control. One of the most effective treatments has been rituximab, a therapy that works by depleting B cells, which are the immune cells that drive inflammation with MS. However, new research from Kaiser Permanente Southern ...